Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma
Transcutaneous and EUS-guided radiofrequency ablation are both modern modalities to apply in the managemnet of various malignancies. In the current study the investigators aim to study the technical feasibility, patient safety and clinical efficacy of EUS-RFA for the treatment of pancreatic insulinoma.
| Condition(s) | Insulinoma; Pancreas |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Transcutaneous and EUS-guided radiofrequency ablation are both modern modalities to apply in the managemnet of various malignancies. In the current study the investigators aim to study the technical feasibility, patient safety and clinical efficacy of EUS-RFA for the treatment of pancreatic insulinoma. |
| Who can participate | Inclusion Criteria: * Insulinoma verified by pathology (often from EUS-FNB-sampling) Exclusion Criteria: * Patients unwilling to participate * Patients unable to understand and obtain written informed conscent * Severe comorbidity |
| Ages | 15 Years to 80 Years |
| Sex | All |
| Lead sponsor | Sahlgrenska University Hospital |
| Locations | Gothenburg, Sweden |
| Start date | 2025-03-31 |
| NCT ID | NCT07585032 |
| Official listing | https://clinicaltrials.gov/study/NCT07585032 |